StockSelector.com
  Research, Select, & Monitor Wednesday, October 17, 2018 6:30:48 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ligand Pharmaceuticals, Inc.$203.01($7.87)(3.73%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Ligand Pharmaceuticals, Inc. has an overall rank of 349 out of 7427 stocks based on 16 positive rankings and 5 negative rankings.

Positive Rankings
Up EPS Surprise
Ligand Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings.
Highest Net Margin
Ligand Pharmaceuticals rank is 122
Positive Guidance
Within the past 90 days Ligand Pharmaceuticals has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Estimated EPS Growth
Ligand Pharmaceuticals rank is 267
Target Prices
The average analysts' target price is $278.67 for Ligand Pharmaceuticals using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Ligand Pharmaceuticals is ranked 317.
Historic Revenue Growth
Ligand Pharmaceuticals rank is 339
Oversold RSI
The 14 Day Relative-Strength Index for Ligand Pharmaceuticals is 29.4. An RSI below 30 indicates the stock is oversold. Among companies with a low RSI, Ligand Pharmaceuticals is ranked 403.
Estimated Revenue Growth
Ligand Pharmaceuticals rank is 477
Oversold Stochastics
Ligand Pharmaceuticals rank is 558
Top Industry Values
Ligand Pharmaceuticals rank is 747
90 Day Gain
Ligand Pharmaceuticals rank is 985
Highest Cash Growth
Ligand Pharmaceuticals rank is 1166
Debt-to-Equity
Ligand Pharmaceuticals rank is 1460
SSValue
The StockSelector Value for Ligand Pharmaceuticals is $232.99. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Ligand Pharmaceuticals is ranked 1649.
Highest ROA
Ligand Pharmaceuticals rank is 2356
Highest ROE
Ligand Pharmaceuticals rank is 2868
Negative Rankings
10 Day Loss
Ligand Pharmaceuticals rank is 172
Price-to-Sales
Ligand Pharmaceuticals rank is 271
Price-to-Book
Ligand Pharmaceuticals rank is 373
High vPut/Call
Ligand Pharmaceuticals has a high Put/Call ratio of 1.05 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ligand Pharmaceuticals is ranked 1272.
High Put/Call
Ligand Pharmaceuticals has a high Put/Call ratio of 0.69 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ligand Pharmaceuticals is ranked 1447.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.